SEC Form 3 · accession 0001193125-26-389379
HCA Healthcare, Inc. · HCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael J Schlosser
Officer — EVP and Chief Clinical Officer
Period of report
Sep 1, 2026
Accepted (ET)
Sep 11, 2026 · 5:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000860730
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 170 | D | ||
| Common Stock | holding | — | — | — | 6,951 | I | By 2022 Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation RightF2 | $81.96 | holding | — | — | — | — | Feb 1, 2027 | Common Stock | 3,030 | — | D |
| Stock Appreciation RightF3 | $82.85 | holding | — | — | — | — | May 3, 2027 | Common Stock | 1,898 | — | D |
| Stock Appreciation RightF4 | $101.16 | holding | — | — | — | — | Jan 31, 2028 | Common Stock | 6,290 | — | D |
| Stock Appreciation RightF5 | $139.06 | holding | — | — | — | — | Jan 30, 2029 | Common Stock | 4,400 | — | D |
| Stock Appreciation RightF6 | $145.24 | holding | — | — | — | — | Jan 29, 2030 | Common Stock | 2,420 | — | D |
| Stock Appreciation RightF7 | $173.12 | holding | — | — | — | — | Feb 3, 2031 | Common Stock | 2,100 | — | D |
| Stock Appreciation RightF8 | $246.79 | holding | — | — | — | — | Jul 22, 2031 | Common Stock | 2,370 | — | D |
| Stock Appreciation RightF9 | $236.61 | holding | — | — | — | — | Jan 28, 2032 | Common Stock | 4,160 | — | D |
| Stock Appreciation RightF10 | $253.30 | holding | — | — | — | — | Jan 30, 2033 | Common Stock | 3,789 | — | D |
| Stock Appreciation RightF11 | $304.90 | holding | — | — | — | — | Jan 31, 2034 | Common Stock | 3,577 | — | D |
| Stock Appreciation RightF12 | $328.70 | holding | — | — | — | — | Jan 28, 2035 | Common Stock | 3,575 | — | D |
| Stock Appreciation RightF13 | $482.53 | holding | — | — | — | — | Jan 29, 2036 | Common Stock | 3,103 | — | D |
Explanation of responses
- F1Includes 170.1027 shares acquired under the Issuer's employee stock purchase plans.
- F10The stock appreciation rights vest in four equal annual installments beginning on January 30, 2024.
- F11The stock appreciation rights vest in four equal annual installments beginning on January 31, 2025.
- F12The stock appreciation rights vest in four equal annual installments beginning on January 28, 2026.
- F13The stock appreciation rights vest in four equal annual installments beginning on January 29, 2027.
- F2The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018.
- F3The stock appreciation rights vested in four equal annual installments beginning on May 3, 2018.
- F4The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019.
- F5The stock appreciation rights vested in four equal annual installments beginning on January 30, 2020.
- F6The stock appreciation rights vested in four equal annual installments beginning on January 29, 2021.
- F7The stock appreciation rights vested in four equal annual installments beginning on February 3, 2022.
- F8The stock appreciation rights vested in four equal annual installments beginning on July 22, 2022.
- F9The stock appreciation rights vested in four equal annual installments beginning on January 28, 2023.